Anne Wojcicki

Learn More
Although the causes of Parkinson's disease (PD) are thought to be primarily environmental, recent studies suggest that a number of genes influence susceptibility. Using targeted case recruitment and online survey instruments, we conducted the largest case-control genome-wide association study (GWAS) of PD based on a single collection of individuals to date(More)
Despite the recent rapid growth in genome-wide data, much of human variation remains entirely unexplained. A significant challenge in the pursuit of the genetic basis for variation in common human traits is the efficient, coordinated collection of genotype and phenotype data. We have developed a novel research framework that facilitates the parallel study(More)
While the cost and speed of generating genomic data have come down dramatically in recent years, the slow pace of collecting medical data for large cohorts continues to hamper genetic research. Here we evaluate a novel online framework for obtaining large amounts of medical information from a recontactable cohort by assessing our ability to replicate(More)
Genetic studies of human disease have traditionally focused on the detection of disease-causing mutations in afflicted individuals. Here we describe a complementary approach that seeks to identify healthy individuals resilient to highly penetrant forms of genetic childhood disorders. A comprehensive screen of 874 genes in 589,306 genomes led to the(More)
At 23andMe, we welcome opportunities to discuss ways in which we can balance the need to educate and protect consumers with our intertwined missions: giving people access to their own personal genetic information (PGI), and creating a novel, participant-driven research model. As the president of the American College of Medical Genetics recently noted, “the(More)
To the Editor: As co-founder and CEO of 23andMe, I was disturbed to read a Correspondence from Geneyouin founder and CEO Ruslan Dorfman in the September issue1 that includes assertions and innuendo regarding my company that are false and misleading. I would like to correct these errors and set the record straight for Nature Biotechnology’s readership. In(More)
While the cost and speed of generating genomic data have come down dramatically in recent years, the slow pace of collecting medical data for large cohorts continues to hamper genetic research. Here we evaluate a novel online framework for amassing large amounts of medical information in a recontactable cohort by assessing our ability to replicate genetic(More)
  • 1